Medtronic Resolute Onyx DES Receives First and Only One-Month DAPT Indication for High Bleeding Risk Patients in Europe
Resolute Onyx DES is available for use in the United States, as well as in Europe and other countries that recognize the CE Mark. Resolute Onyx DES is not currently indicated for HBR patients with one-month DAPT in the United States. Data have been submitted to the FDA with the intent of obtaining a one-month DAPT US Indication for Resolute Onyx DES.
FDA Approves Antibiotic to Treat Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia
Approval of this indication is based on limited clinical safety and efficacy data for Recarbrio.
Rich Fabian President and CEO of FUJIFILM Sonosite Elected To Life Science Washington Executive Committee
Fabian, President and COO of FUJIFILM Sonosite, Inc., calls LSW "a primary venture ignitor and attractor" helping to accelerate the state's progress in life sciences and research
COVID-19 Diagnostic Testing Market: Insights, Competition and 2020-2025 Forecast
The Global COVID-19 Diagnostic Testing Market is estimated to be valued at USD 44,481.8 million for the year 2020 owing to a rapid increase in the number of coronavirus cases across the globe which boosts the demand for COVID-19 diagnostic tests.
Jupiter Medical Center Appoints Dr. Charles Murphy as Chief Quality and Patient Safety Officer
Dr. Charles Murphy most recently served as chief patient safety officer at the Inova Heart and Vascular Institute based in Falls Church, Virginia.